Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityNo recent work listed

Wei Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5043-6692; OpenAlex author ID A5101475506. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. DDX18 drives tumor immune escape through transcription-activated STAT1 expression in pancreatic cancer. Co-author DOI 10.1038/s41388-023-02817-0↗
  2. [Corrigendum] Expression and prognostic significance of TRPV6 in the development and progression of pancreatic cancer. Last author DOI 10.3892/or.2022.8395↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Song He · 1 shared paper, 2022 · strength 0.19
  2. Weiwei Sheng · 1 shared paper, 2022 · strength 0.19
  3. Ming Dong · 1 shared paper, 2022 · strength 0.19
  4. Jianping Zhou · 1 shared paper, 2022 · strength 0.19
  5. Shujun Zhang · 1 shared paper, 2023 · strength 0.18
  6. Guoying Dong · 1 shared paper, 2023 · strength 0.18
  7. Chuanxin Wang · 1 shared paper, 2023 · strength 0.18
  8. Huaizhi Wang · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.